Your browser doesn't support javascript.
loading
Emulsion and liposome-based adjuvanted R21 vaccine formulations mediate protection against malaria through distinct immune mechanisms.
Reinke, Sören; Pantazi, Eirini; Chappell, Gabrielle R; Sanchez-Martinez, Alexandra; Guyon, Romain; Fergusson, Joannah R; Salman, Ahmed M; Aktar, Anjum; Mukhopadhyay, Ekta; Ventura, Roland A; Auderset, Floriane; Dubois, Patrice M; Collin, Nicolas; Hill, Adrian V S; Bezbradica, Jelena S; Milicic, Anita.
Affiliation
  • Reinke S; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7DQ, UK.
  • Pantazi E; Kennedy Institute of Rheumatology Research, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Medical Sciences Division, University of Oxford, Oxford OX3 7FY, UK.
  • Chappell GR; Kennedy Institute of Rheumatology Research, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Medical Sciences Division, University of Oxford, Oxford OX3 7FY, UK.
  • Sanchez-Martinez A; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7DQ, UK.
  • Guyon R; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7DQ, UK.
  • Fergusson JR; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7DQ, UK.
  • Salman AM; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7DQ, UK.
  • Aktar A; Kennedy Institute of Rheumatology Research, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Medical Sciences Division, University of Oxford, Oxford OX3 7FY, UK.
  • Mukhopadhyay E; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7DQ, UK.
  • Ventura RA; Vaccine Formulation Institute, Rue du Champ-Blanchod 4, 1228 Plan-Les-Ouates, Switzerland.
  • Auderset F; Vaccine Formulation Institute, Rue du Champ-Blanchod 4, 1228 Plan-Les-Ouates, Switzerland.
  • Dubois PM; Vaccine Formulation Institute, Rue du Champ-Blanchod 4, 1228 Plan-Les-Ouates, Switzerland.
  • Collin N; Vaccine Formulation Institute, Rue du Champ-Blanchod 4, 1228 Plan-Les-Ouates, Switzerland.
  • Hill AVS; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7DQ, UK.
  • Bezbradica JS; Kennedy Institute of Rheumatology Research, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Medical Sciences Division, University of Oxford, Oxford OX3 7FY, UK. Electronic address: jelena.bezbradica@kennedy.ox.ac.uk.
  • Milicic A; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7DQ, UK. Electronic address: anita.milicic@ndm.ox.ac.uk.
Cell Rep Med ; 4(11): 101245, 2023 11 21.
Article in En | MEDLINE | ID: mdl-37913775
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Malaria Vaccines / Malaria Limits: Animals Language: En Journal: Cell Rep Med Year: 2023 Type: Article Affiliation country: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Malaria Vaccines / Malaria Limits: Animals Language: En Journal: Cell Rep Med Year: 2023 Type: Article Affiliation country: United kingdom